Hemangiosarcoma
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Hemangiosarcoma Classification and external resources | |
| ICD-9 | 155, others |
|---|---|
| ICD-O: | 9120/3 |
|
WikiDoc Resources for Hemangiosarcoma | |
|
Articles | |
|---|---|
|
Most recent articles on Hemangiosarcoma Most cited articles on Hemangiosarcoma | |
|
Media | |
|
Powerpoint slides on Hemangiosarcoma | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Hemangiosarcoma at Clinical Trials.gov Trial results on Hemangiosarcoma Clinical Trials on Hemangiosarcoma at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Hemangiosarcoma NICE Guidance on Hemangiosarcoma
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Hemangiosarcoma Discussion groups on Hemangiosarcoma Patient Handouts on Hemangiosarcoma Directions to Hospitals Treating Hemangiosarcoma Risk calculators and risk factors for Hemangiosarcoma
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Hemangiosarcoma | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Hemangiosarcoma is a rare, rapidly growing, highly invasive variety of cancer. It is a blood-fed sarcoma; that is, blood vessels grow directly into the tumor and it is typically filled with blood. A frequent cause of death is the rupturing of this tumor, causing the victim to rapidly bleed to death.
The phrase "angiosarcoma", when used without modifier, usually refers to hemangiosarcoma. However, glomangiosarcoma (8710/3) and lymphangiosarcoma (9170/3) are distinct conditions. Hemangiosarcomas are commonly associated with toxic exposure to thorium dioxide (Thorotrast), vinyl chloride, and arsenic.
de:Angiosarkom
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
